Eli Lilly plans to acquire Dice Therapeutics — a biopharmaceutical company that develops oral therapeutics for autoimmune diseases — in a deal valued at $2.4 billion. 

Louisiana passed a bill that prevents drugmakers from restricting 340B-discounted drugs to safety-net hospitals' contract pharmacies. The law is effective Aug. 1. 

The Accreditation Council for Medical Affairs on June 20 unveiled the first and only accredited certification for nurses wanting to transition to the biopharmaceutical industry. 

FDA investigators discovered more quality issues at an Intas Pharmaceuticals factory in Ahmedabad, India, which halted some production after a November inspection found a truck full of shredded documents, Bloomberg reported June 15. 

In two days, two Cambridge, Mass.-based pharma companies have paused their cancer drug trials after six patients died. 

Major Pharmaceutical/Rugby Laboratories, based in Livonia, Mich., is recalling one lot of an anti-nausea drug because a distributor found it to be mislabeled as the drugmaker's schizophrenia drug.

A 52-week phase 3 clinical trial of Skyrizi, or risankizumab — a drug initially approved to treat Crohn's disease, psoriatic arthritis and psoriasis — was shown to also achieve clinical remission in 40 percent of patients with ulcerative colitis, AbbVie…

On Nov. 1, the new U.S. Pharmacopoeia standards on sterile and nonsterile compounding will be implemented. Here's what leaders need to know about USP 795 and USP 797: 

The Inflation Reduction Act could offer cancer patients annual savings of $7,590 on average, and some patients could save up to $19,296, according to a June 14 report from Patients for Affordable Drugs. 

Seattle Children's Hospital paused a sponsored clinical study of a leukemia drug candidate after the first patient to take the medication died, according to the oncology cell-therapy company 2seventy Bio.